Tagworks Pharmaceuticals
PrivateLast Round
Series A
Jun 22, 2023
Total Funding Raised
$74M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Tagworks Pharmaceuticals is a biotechnology company that develops precision oncology treatments using its proprietary Click-to-Release technology to enable controlled drug release in the tumor microenvironment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tagworks Pharmaceuticals Comparables
Compare Tagworks Pharmaceuticals with similar companies based on industry and business-model similarity.
Tagworks Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 22, 2023 | ||||
| Seed | Nov 27, 2021 | ||||
| Grant | Dec 18, 2015 |
Tagworks Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BIF Partners | Seed, Series A |
| New Enterprise Associates | Series A |
| Lightstone Ventures | Series A |
| Ysios Capital | Series A |
| Gilde Healthcare | Series A |
| European Union's Horizon 2020 | Grant |
| Meneldor | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 161% MoM.
- Oct 15, 2025
First-in-human Phase 0/1 study of TGW211 begins for HER2-positive solid tumors.
Tagworks Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tagworks Pharmaceuticals's valuation, stock price, and market status.
Is Tagworks Pharmaceuticals a public or private company?
Tagworks Pharmaceuticals is a private company.
What is the current stock price of Tagworks Pharmaceuticals?
Tagworks Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Tagworks Pharmaceuticals worth (valuation)?
Valuation information for Tagworks Pharmaceuticals is not publicly available.
Can I buy Tagworks Pharmaceuticals stock?
Tagworks Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tagworks Pharmaceuticals's last funding round?
Tagworks Pharmaceuticals's most recent funding round was Series A on June 22, 2023.
Who are the main investors in Tagworks Pharmaceuticals?
Key investors in Tagworks Pharmaceuticals include Ysios Capital, Gilde Healthcare, Meneldor, Oost NL.
Will Tagworks Pharmaceuticals IPO soon?
No public IPO plans have been announced for Tagworks Pharmaceuticals.
How can I track Tagworks Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tagworks Pharmaceuticals's secondary market activity and sign up for updates.